Article summary
This randomised, blinded feasibility study (n=13) tested whether healthy adults could complete physiotherapist-led movement tasks after psilocybin (5 mg, 10 mg, 15 mg and 20 mg), and found the tasks were manageable up to 15 mg, with impairment at 20 mg on tasks combining movement with cognitive demands. Nausea and headache were common, and no serious adverse events occurred.
Continue to the original publication for the complete article.